Home » Headlines » Currently Reading:

Morning Headlines 5/6/15

May 5, 2015 Headlines No Comments

Cognizant Earnings Top, Fueled By TriZetto Buy

Cognizant reports Q1 results: revenue up 20 percent to $2.9 billion, EPS $0.62 vs. $0.57, beating analyst estimates on both. The company’s stock price climbed 10.8 percent, to a record high $65.55, following the results.

Imprivata Achieves Revenue Growth of 32% for the First Quarter of 2015 and Raises Annual Guidance

Imprivata reports Q1 results: revenue up 32 percent to $25 million but still resulted in an overall net loss of $6.7 million, EPS –$0.28 vs. –$2.29, beating expectations for both.

Overkill: An avalanche of unnecessary medical care is harming patients physically and financially. What can we do about it?

In a New Yorker piece, Atul Gawande, MD discusses the tendency to overtreat patients in the US, citing a study suggesting that, every year, at least 25 percent of Medicare patients receive high-cost tests that are well known to be wasteful.

Apple Has Plans for Your DNA

Apple will begin offering DNA testing to some iPhone owners to support current and future ResearchKit initiatives. UCSF and Mount Sinai Hospital are planning ResearchKit-based studies that involve DNA testing.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...
  • Mike: I would love to see this type of discussion around Blockchain. It is being hyped heavily currently. Yet, I wonder how we...
  • Brian Too: Just slightly off-topic, but I recently heard an interesting downtime rule-of-thumb: Every hour of downtime requires 2 ...
  • James E Thompson: AI in particular isn't disruptive until it can offer an effective alternative against which a go/no-go decision makes se...
  • Former Newspaper Guy: I applaud your attention to grammar and style. In high school, I worked for the local newspaper in the sports department...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links